Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 729 JPY 0.26% Market Closed
Market Cap: 425.9B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Kobayashi Pharmaceutical Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kobayashi Pharmaceutical Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Capital Expenditures
-ÂĄ27.5B
CAGR 3-Years
-94%
CAGR 5-Years
-46%
CAGR 10-Years
-23%
Shiseido Co Ltd
TSE:4911
Capital Expenditures
-ÂĄ53.3B
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
-9%
Rohto Pharmaceutical Co Ltd
TSE:4527
Capital Expenditures
-ÂĄ10.1B
CAGR 3-Years
5%
CAGR 5-Years
-15%
CAGR 10-Years
-6%
Kao Corp
TSE:4452
Capital Expenditures
-ÂĄ64.7B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Kose Corp
TSE:4922
Capital Expenditures
-ÂĄ7.6B
CAGR 3-Years
-4%
CAGR 5-Years
18%
CAGR 10-Years
-7%
F
Fancl Corp
TSE:4921
Capital Expenditures
-ÂĄ2.3B
CAGR 3-Years
36%
CAGR 5-Years
16%
CAGR 10-Years
2%
No Stocks Found

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
425.9B JPY
Industry
Consumer products

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,451 full-time employees. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

Intrinsic Value
6 884.48 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Kobayashi Pharmaceutical Co Ltd's Capital Expenditures?
Capital Expenditures
-27.5B JPY

Based on the financial report for Jun 30, 2024, Kobayashi Pharmaceutical Co Ltd's Capital Expenditures amounts to -27.5B JPY.

What is Kobayashi Pharmaceutical Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-23%

Over the last year, the Capital Expenditures growth was -45%. The average annual Capital Expenditures growth rates for Kobayashi Pharmaceutical Co Ltd have been -94% over the past three years , -46% over the past five years , and -23% over the past ten years .

Back to Top